Aller au contenu principal
Profil bibliographique

Emily J. Kirsch

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

26Publications signalées
381Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Fungal Infections and StudiesAntifungal resistance and susceptibilityNail Diseases and TreatmentsColorectal Cancer Screening and DetectionEthics in Clinical Research

Les publications récentes

2025 conference-abstract OpenAlex

Abstract B069: On the development of the Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts biobank

Janet E. Olson, Shounak Majumder, Jennifer Brooks, Emily J. Kirsch et autres

Abstract Background: The Pancreatic Cancer Detection Consortium (PCDC) is an NCI-sponsored initiative to improve detection of early-stage pancreatic ductal adenocarcinoma (PDAC). A key strategy in this initiative is to develop prospective, multi-center, longitudinal biospecimen collections from individuals without PDAC who are at …

us (code pays fourni par la source)

0 citations Cancer Research
2025 conference-abstract OpenAlex

Abstract 7354: Patient reported outcome validation within the Voyage Study cohort

Emily J. Kirsch, Jessica A. Grimm, Shawn M. Stoddard, Winnie Z. Fan et autres

Abstract Background: Epidemiologic studies commonly obtain important exposure and outcome information from patient self-report although these may be influenced by imperfect understanding and/or faulty recall. The Voyage Study is a large-scale, prospective cohort study of long-term health outcomes among participants with a …

us (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2024 article OpenAlex

Recruitment strategies and consent rates in a national prospective colorectal cancer screening cohort: results from year 1 of the Voyage Study

Kathleen J. Yost, Rachel E. Carlson, Christine R. Kirt, Emily J. Kirsch et autres

OBJECTIVE: To identify the optimal incentive protocol for maximising participation while managing study costs during the Voyage trial. DESIGN: Prospective cohort (Voyage trial) of colorectal cancer (CRC) incidence and mortality outcomes in individuals screened with multitarget stool DNA (mt-sDNA) served as the …

us (code pays fourni par la source)

1 citation BMJ Open Gastroenterology
2024 conference-abstract OpenAlex

Abstract 3453: U.S. Geographic and socio-demographic characteristics of Voyage Study participants

Allison M. Berry, Jessica A. Grimm, Christine R. Kirt, Emily J. Kirsch et autres

Abstract The Voyage Study is a large-scale, prospective cohort study of long-term health outcomes among participants with a valid multi-target stool DNA (mt-sDNA) test order. Recently, the Voyage Study achieved its enrollment target of 150,000 participants. The intent of this descriptive analysis …

us (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2023 preprint OpenAlex

Recruitment Strategies and Consent Rates in a National Prospective Colorectal Cancer Screening Cohort: Results from Year 1 of the Voyage Study

Kathleen J. Yost, Rachel E. Carlson, Christine R. Kirt, Emily J. Kirsch et autres

Abstract Background: Adherence to recommended colorectal cancer (CRC) screening among US adults is below the public health target of 80%. The multi-target stool DNA assay (mt-sDNA) is a self-administered CRC screening test that may remove barriers to adherence. To improve understanding of …

us (code pays fourni par la source)

2 citations Research Square
Accès ouvert 2020 article OpenAlex

Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study)

Janet E. Olson, Emily J. Kirsch, David K. Edwards, Christine R. Kirt et autres

Introduction: Population-level screening has been shown to reduce the incidence and mortality of colorectal cancer (CRC). Unfortunately, adherence to screening recommendations among eligible US adults remains below national goals. A relatively new non-invasive screening modality, the Food and Drug Administration-approved multi-target stool …

us (code pays fourni par la source)

13 citations BMJ Open Gastroenterology
2015 article OpenAlex

Evaluation of an enzyme immunoassay for antibodies to a recombinant Blastomyces adhesin-1 repeat antigen as an aid in the diagnosis of blastomycosis in dogs

Alyssa C. Mourning, Edward E. Patterson, Emily J. Kirsch, Janelle Renschler et autres

OBJECTIVE: To evaluate the sensitivity and specificity of an enzyme immunoassay (EIA) for antibodies to a recombinant Blastomyces adhesin-1 repeat antigen (rBAD-1) to aid in the diagnosis of blastomycosis in dogs and compare the findings with results from other tests used for …

us, hu, gb (code pays fourni par la source)

16 citations Journal of the American Veterinary Medical Association
2015 article OpenAlex

Sensitivity and Specificity of Histoplasma Antigen Detection by Enzyme Immunoassay

Lauren Cunningham, Audrey K. Cook, Andrew S. Hanzlicek, Kenneth R. Harkin et autres

The objective of this study was to evaluate the sensitivity and specificity of an antigen enzyme immunoassay (EIA) on urine samples for the diagnosis of histoplasmosis in dogs. This retrospective medical records review included canine cases with urine samples submitted for Histoplasma …

us, de, gb (code pays fourni par la source)

33 citations Journal of the American Animal Hospital Association
Accès ouvert 2014 letter OpenAlex

Reply to “Insufficient Demonstration of Long-Term Stability of Aspergillus Galactomannan”

L. Joseph Wheat, M. Hong Nguyen, Barbara D. Alexander, David W. Denning et autres

We thank Dr. Johnson and coauthors for reemphasizing in [their letter][1] ([1][2]) some of the limitations of our study of the stability of galactomannan in frozen specimens ([2][3]), namely, the small sample size, lack of clinical information, and potential for confounding factors …

us, gb (code pays fourni par la source)

3 citations Journal of Clinical Microbiology
Accès ouvert 2014 article OpenAlex

Long-Term Stability at −20°C of Aspergillus Galactomannan in Serum and Bronchoalveolar Lavage Specimens

L. Joseph Wheat, M. Hong Nguyen, Barbara D. Alexander, David W. Denning et autres

Research to develop and validate novel methods for diagnosis of aspergillosis based on detection of galactomannan requires the use of clinical specimens that have been stored frozen. Data indicating that galactomannan remains stable when frozen are scant. The objective of this study …

us, gb (code pays fourni par la source)

17 citations Journal of Clinical Microbiology
Accès ouvert 2014 article OpenAlex

Serum and Urine Blastomyces Antigen Concentrations as Markers of Clinical Remission in Dogs Treated for Systemic Blastomycosis

Daniel S. Foy, Lauren A. Trepanier, Emily J. Kirsch, L. Joseph Wheat

BACKGROUND: Serum and urine Blastomyces antigen concentrations can be used to diagnose blastomycosis in dogs. OBJECTIVES: Blastomyces antigen concentrations correlate with clinical remission in dogs during antifungal treatment, and detect disease relapse after treatment discontinuation. ANIMALS: 21 dogs with newly diagnosed blastomycosis …

us, de (code pays fourni par la source)

36 citations Journal of Veterinary Internal Medicine
Accès ouvert 2012 article OpenAlex

Histoplasmosis among hospitalized febrile patients in northern Tanzania

Sarah M Lofgren, Emily J. Kirsch, Venance P. Maro, Anne B. Morrissey et autres

Histoplasmosis may be common in East Africa but the diagnosis is rarely confirmed. We report 9 (0.9%) cases of probable histoplasmosis retrospectively identified among 970 febrile inpatients studied in northern Tanzania. Median (range) age was 31 (6, 44) years, 6 (67%) were …

us, in, Tanzanie (code pays fourni par la source)

49 citations Transactions of the Royal Society of Tropical Medicine and Hygiene

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.